+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Pyrogen Testing Market: Development of New Drugs to Improve Health Provides Impetus, notes TMR

Posted on Mar 22, 2017

The competitive landscape of the global pyrogen testing market is an extremely consolidated one. Thermofisher, Charles River Laboratories International, Inc., Lonza Group, and Merck KGaA collectively held a share of 51% in the global market. Genscript, Hyglos Gmbh, Associates of Cape Cod, Inc., and Wako Chemicals USA, Inc. are some of the leading players operating in the market. 

The established players are anticipated to maintain their leadership as they are concentrated on strategic acquisitions and mergers and on developing products that do not necessitate rabbit pyrogen testing. A case in point would be Thermo Fisher Scientific, Inc. In March 2016, Thermo Fisher Scientific collaborated with the University of Birmingham in the U.K. to supply a range of advanced mass spectrometry instruments to the center for research purpose. In the same year in May, this company acquired FEI Company, a high-performance electron microscopy company. This acquisition is likely to help the company strengthen its presence in the global market. According to the TMR report, the global pyrogen testing market is anticipated to grow from its original valuation of US$570.0 mn in 2015 to US$1,527.8 mn by 2024, and is likely to advance at a CAGR of 11.9% within the forecast period of 2016 to 2024. 

pyrogen testing market

Big Investments by Major Players to Help North America Grow 

Geographically, the global pyrogen testing market is led by North America. In 2015, this region held a share of 38.6% in the market. Key players in the market have a strong presence in this region and are making huge investments in research and development, which is the primary factor driving the growth in North America. In addition, favorable support from the governments is also fuelling the growth of the market. Developing economies of Asia Pacific and Latin America are also expected to grow over the forecast period due to their progressive medical tourism.

In terms of tests, the limulus amoebocyte lysate (LAL) test is being extensively implemented by several drug manufacturing companies. It is expected to grow further in the forecast period as it offers the best quality control. This testing method is being used for detecting the microscopic quantity of bacterial toxins or pyrogen in pharmaceuticals, medical devices, and other areas. 

High Expenditure on Healthcare to Boost Pyrogen Testing 

The global pyrogen testing market is driven by several factors, the key one being the advent of biotechnology and pharmaceutical companies across the globe. In addition, increased investments in the development of new drugs to improve healthcare is expected to impel the demand for pyrogen testing. Rise in incidence of chronic diseases, coupled with introduction of innovative drugs, launch of biological products, and favorable government initiatives will supplement the growth of the global market. Moreover, the market is expected to develop further owing to growing expenditure on healthcare, favorable reimbursement policies, and increasing responsiveness about chronic conditions. 

On the other hand, the market is expected to face a major a setback due to ongoing efforts to ban animal testing. Plus, high costs of tests such as Monocyte activation test (MAT) will exacerbate the market growth. 

This review is based on the findings of a TMR report titled ‘Pyrogen Testing Market (Test Type - Recombinant Factor C Assay (rFC), Monocyte Activation Test (MAT), Limulus Amoebocyte Lysate (LAL) Test, and Rabbit Pyrogen Test (RPT); Component - Instruments, Kits, and Reagents; End User - Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food & Beverage Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.’ 

Global Pyrogen Testing Market, by Test Type

  • Recombinant Factor C Assay (rFC)
  • Monocyte Activation Test (MAT)
  • Limulus Amoebocyte Lysate (LAL) Test
  • Rabbit Pyrogen Test (RPT) 

Global Pyrogen Testing Market, by Component

  • Instruments
  • Kits
  • Reagents 

Global Pyrogen Testing Market, by End-user

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Food & Beverage Companies
  • Others 

Global Pyrogen testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top